Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]

Blog Article

Hashimoto S, Ikeuchi H, Murata S, Kitawaki T, Ikeda K, Banerji D.Int J Chron Obstruct Pulmon Dis.2016;11:2543–2551.

 On page 2547, Figure 5, x-axis, the dose mentioned royal nomadic 5413 rug in the label for IND should have read “150 μg od” instead of “110 μg od” and the dose for GLY should have read “50 μg il barone wine od” instead of “110 μg od”.Read the original article here. .